Brendan Teehan Acadia Pharmaceuticals Inc (ACAD) insider trading activity

Brendan Teehan is EVP, COO, HEAD OF COMMERCIAL of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 62,105 shares of ACAD, which is worth approximately $1.07 Million. The most recent transaction as insider was on Jan 06, 2023, when has been sold 1,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.1K

19.03% 3M change

100.67% 12M change

Total Value Held $1.07 Million

Brendan Teehan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2023	BUY Exercise of conversion of derivative security	-	1,286 Added 20.2%	5,081 Common Stock
May 02 2022	SELL Open market or private sale	$10,035 $18.18 p/Share	552 Reduced 13.84%	3,437 Common Stock
Apr 29 2022	BUY Exercise of conversion of derivative security	-	1,567 Added 28.2%	3,989 Common Stock
Feb 23 2022	SELL Open market or private sale	$11,234 $23.8 p/Share	472 Reduced 16.31%	2,422 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	-	1,106 Added 27.65%	2,894 Common Stock
Jan 06 2022	SELL Open market or private sale	$12,401 $23.05 p/Share	538 Reduced 23.13%	1,788 Common Stock
Jan 06 2022	BUY Exercise of conversion of derivative security	-	1,286 Added 35.6%	2,326 Common Stock

Brendan Teehan

EVP, COO, HEAD OF COMMERCIAL

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Value

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD

Account